Bio Essence Corp financial data

Symbol
BIOE on OTC
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7.64 % -68.8%
Quick Ratio 6.07 % -5.3%
Debt-to-equity -108 % +46%
Return On Equity 5.19 % -93.1%
Return On Assets -67.99 % +9.8%
Operating Margin -62.66 % +23.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38,009,000 shares 0%
Common Stock, Shares, Outstanding 38,009,000 shares 0%
Entity Public Float 26,844,590 USD
Common Stock, Value, Issued 3,801 USD 0%
Weighted Average Number of Shares Outstanding, Basic 38,009,000 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 38,009,000 shares +9.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 136,800 USD +1.6%
Cost of Revenue 41,040 USD -23.6%
General and Administrative Expense 516,462 USD -32.8%
Operating Income (Loss) -125,765 USD +80.9%
Nonoperating Income (Expense) -33,889 USD +96.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -159,654 USD +90.7%
Income Tax Expense (Benefit) 800 USD 0%
Net Income (Loss) Attributable to Parent -160,453 USD +89.1%
Earnings Per Share, Basic 0 USD/shares -50%
Earnings Per Share, Diluted 0 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28,741 USD -3.6%
Accounts Receivable, after Allowance for Credit Loss, Current 4,969 USD -92.4%
Inventory, Net 143,259 USD -20.9%
Assets, Current 184,378 USD -74.2%
Property, Plant and Equipment, Net 3,688 USD -98.5%
Operating Lease, Right-of-Use Asset 1,178,577 USD +20.8%
Intangible Assets, Net (Excluding Goodwill) 156 USD -60.1%
Other Assets, Noncurrent 274 USD -99.5%
Assets 184,534 USD -74.2%
Accounts Payable, Current 10,608 USD -67%
Accrued Liabilities, Current 3,301 USD -51.1%
Liabilities, Current 3,230,021 USD +5.3%
Operating Lease, Liability, Noncurrent 99,668 USD -85.2%
Other Liabilities, Noncurrent 301,959 USD +4.4%
Liabilities 3,286,514 USD -10.1%
Retained Earnings (Accumulated Deficit) -10,582,160 USD -1.5%
Stockholders' Equity Attributable to Parent -3,101,980 USD -5.5%
Liabilities and Equity 184,534 USD -74.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -26,069 USD +84.8%
Net Cash Provided by (Used in) Financing Activities 24,698 USD -85.6%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 38,009,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 23 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28,741 USD -3.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 543 USD -88.4%
Deferred Tax Assets, Valuation Allowance 1,326,082 USD +1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 699,042 USD +12.1%
Operating Lease, Liability 1,394,037 USD
Depreciation 238 USD
Lessee, Operating Lease, Liability, to be Paid 1,558,577 USD
Property, Plant and Equipment, Gross 56,505 USD 0%
Operating Lease, Liability, Current 1,496,907 USD +64.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 587,978 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 570,852 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 3,200 USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 124,951 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 399,747 USD
Deferred Tax Assets, Operating Loss Carryforwards 1,325,904 USD
Current Income Tax Expense (Benefit) 3,200 USD 0%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital 7,476,379 USD 0%
Amortization of Intangible Assets 58 USD -75.3%
Depreciation, Depletion and Amortization 497 USD -80%
Interest Expense 542 USD -2.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%